Skip to content

Efficacy of Thulium laser resection of bladder tumors versus conventional transurethral resection of bladder tumors: a randomized controlled trial

Efficacy of Thulium laser resection of bladder tumors versus conventional transurethral resection of bladder tumors: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035407
Enrollment
Unknown
Registered
2020-08-10
Start date
2020-08-15
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-muscle-invasive bladder cancer

Interventions

Tulium laser group:Tulium laser en-bloc resection of bladder tumors
electrical surgery group:conventional transurethral resection of bladder tumors

Sponsors

Tongji Hospital, Tongji Medical College, Huahzong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients who have primary single or multiple bladder neoplasms 2.Patients who have no upper urinary tract abnormalities, so that the confounding bias could be controlled 3.Patients who have no extravesical extension, lymph node metastasis, or adjacent organ invasion though imaging examinations, such as computed tomography (CT), magnetic resonance urography (MRU) or positron emission tomography(PET)-CT.

Exclusion criteria

Exclusion criteria: 1.Patients who have serious heart, lung, liver, kidney diseases and other severe conditions 2.Patients who could not tolerate the general anesthesia 3.Patients who refuse to receive the treatment or follow-up 4.Patients who unable to underwent a standard treatment under the doctors guidance 5.Patients who are diagnosed as muscle-invasive bladder cancer through postoperative pathological assessments.

Design outcomes

Primary

MeasureTime frame
recurrence-free survival;progression-free survival;

Secondary

MeasureTime frame
postoperative irrigation;overall survival;

Countries

China

Contacts

Public ContactHeng Li

Tongji Hospital, Tongji Medical College, Huahzong University of Science and Technology

lihengtjmu@163.com+86 18986292538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026